Accueil   Diary - News   All news Novadiscovery welcomes two new members to its team...

Novadiscovery welcomes two new members to its team…

to strengthen its combined expertise in artificial intelligence
and clinical medicine

 

  • David duVerle, PhD, previously academic researcher in computational biology and bioinformatics in Tokyo, Japan, notably at the University of Tokyo, becomes Chief Scientific Officer of the company
  • Professor Marc Hommel, neurologist at CHU Grenoble and professor at the faculty of medicine Grenoble Alps, is appointed as Vice President of Medicine of NOVADISCOVERY

 

 

 NOVADISCOVERY, a pioneer in in silico clinical trials, today announced the strengthening of its team with the nomination of its new Chief Scientific Officer, David duVerle, and the appointment of Prof. Marc Hommel as VP of Medicine.

These two arrivals are critical and in line with NOVA’s strategy of conjugating mechanistic (top-down) and data-heavy (bottom-up) approaches to perfect the use of AI and machine learning in drug research and development.

 

 

Read the press release

 

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree